Phosphodiesterase-5 inhibitor (PDE-5i)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Phosphodiesterase-5 inhibitor (PDE-5i), covering 2025-07-09 to 2025-07-09. Get the full timeline:
Most recent: Clinical Trial Update: Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy [NA]